Peter Reynolds

The life and times of Peter Reynolds

Posts Tagged ‘Centre for Medicinal Cannabis

An Update On CBD, the Novel Food Scam and the Fatcats Who Plan to Take Over the Market.

with 3 comments

The CBD Market Has Been Built By Small British Businesses.

It is About To Be Stolen By Government-Backed Big Business.

Over about the last five years, small British businesses have built the CBD market from zero to hundreds of millions in annual sales. It’s been driven by rapidly changing attitudes towards cannabis and a realisation that many of its medicinal benefits could be available legally by using traditional hemp extracts.

Big business, the established supplement and health food companies weren’t interested. They saw the stigma around cannabis before they saw the changing attitudes.

Now it’s all very different. Millions of people are using CBD. All the big multiples are stocking it. It’s become a media fascination and many people say they gain great benefit from it. Suddenly, big business and all the regulators are interested. Suddenly those who weren’t bothered previously are cautioning about all sorts of dangers and concerns. They don’t actually have any evidence of CBD products causing any harm but clearly they don’t think these small, independent businesses can be trusted anymore. Of course, the truth is they want a slice of the action – or preferably all of the action if they can get their chums in government and the bureaucracy to step in and assist with their plans.

In fact the British CBD industry has been a model of responsible self-regulation. Two trade associations, the CTA and CannaPro, represent virtually all the leading UK suppliers and maintain high levels of quality control and trading standards, including regular reporting of non-compliant businesses to the MHRA.

But in June this year, the Centre for Medicinal Cannabis (CMC) published a sensational report alleging that most of the CBD on the market was very poor quality, contained illegal levels of THC and some contained no CBD at all.

Its report was presented as some sort of independent, academic study that should be regarded as science. It wasn’t. It was a cheap marketing stunt. Sure enough, just a few  weeks later it announced that all its members’ products were good quality and there was no problem with them.

Now the CMC has thrown itself in with the EU and is backing the classification of CBD products as ‘novel foods’, meaning that any business selling CBD would have to apply for an authorisation at a cost of at least £250,000 in a process taking perhaps two years to complete.  The CMC has also aligned itself with an interpretation of the law on THC levels in CBD products which is completely at odds with the established industry.  It has sided with the Home Office that there cannot be any THC at all, whereas the industry relies on a  definition of ‘exempt products’ in the Misuse of Drugs Regulations 2001 which permits up to 1mg of THC in each container.

As Brexit approaches, the Food Standards Agency (FSA) is expected to issue guidance on enforcement of the novel foods classification.  If it acts before Brexit then the position will be carried over in the Withdrawal Agreement.  And now the CMC has launched yet another trade body, the Association for the Cannabinoid Industry, (ACI) which it is implying will enable CBD suppliers to enjoy a ‘grace period’ from FSA enforcement.

It would be unlawful for the FSA to make any arrangements or offer any ‘grace period’ to CMC or ACI members that is not available to any other business. Mike Harlington of the CTA tried this on before, claiming he had made special arrangements with the FSA for CTA members only. None of this is true. These claims are confidence tricks but the CMC/ACI is pushing it with the requirement to sign up to membership at a cost said to be between £10,000 and £50,000 per year, completely prohibitive for the small businesses that have worked so hard to develop this industry.

The Centre For Medicinal Cannabis Is A Wolf In Sheep’s Clothing,

The ‘Big Pharma’ Of British Medicinal Cannabis And CBD.

The CMC appeared sometime in 2018 announcing itself as the UK’s first and only industry membership body for businesses and investors operating in cannabis based medicinal products (CBMPs) and cannabidiol (CBD) wellness markets.  This, of course, is nonsense. It’s about the fifth or sixth to set itself up as a trade body in this market and it’s certainly not the only.  Between them, the CTA and CannaPro represent hundreds of businesses with millions of satisfied customers.  The CMC has only a handful of members.

What the CMC/ACI does have is a great deal of money from its backer, the multimillionaire Paul Birch and a great deal of influence from ex-David Cameron ‘fixer’, Steve Moore, who knows all the right people in all the establishment elites and knows how to pull their strings.  In just a few short months it has pumped a fortune into PR and media relations and made itself the go to source for anything on medicinal cannabis and CBD.  It has also bought and paid for a large number of highly qualified people with impressive credentials who inevitably carry great weight with the authorities. Its ambitions are clear.  It intends to destroy the small businesses that built this market and seize it all for itself and it looks as though it may well succeed.

CannaPro spoke with the FSA earlier this week.  For the moment, the FSA cannot act as we are in election ‘purdah’, the civil service can’t really do anything except keep the status quo but that will all change after the election.  Then, depending on the new government, it may move rapidly to commence enforcement. What this will mean is impossible to predict but almost certainly the multiples will take stock off the shelves unless some interim arrangements are agreed.  Those with retail premises will be in the most immediate danger, online sellers will be in a better position but if Trading Standards officers try to seize stock, they have extraordinary powers and trying to obstruct them may result in arrest.

Of course, the novel foods classification is fake and a lot of evidence has been presented to prove this but it is simply being dismissed. It’s rather like the way the medical establishment dismisses the evidence on medicinal cannabis.  If these institutions don’t like evidence they simply ignore it.  For obvious reasons, it suits the CMC to get behind the novel food scam but the result for consumers will be a lot less choice and probably substantial price rises. It’s also very bad news for CBD businesses.  A lot of people are likely to lose their jobs.

 

Written by Peter Reynolds

October 31, 2019 at 9:35 pm

Centre for Medicinal Cannabis CBD Report Confirmed as Cheap Marketing Stunt

leave a comment »

Steve Moore, ex-advisor to David Cameron, now leads the Centre for Medicinal Cannabis

At the end of June, the ‘Centre for Medicinal Cannabis’ (CMC) published a report which painted an appalling picture of the CBD market in the UK and has led to headlines and alarm everywhere that consumers are being ripped off and the whole industry is not to be trusted. See: Mischievous ‘Centre for Medicinal Cannabis’ Report Smears UK CBD Industry With Misleading Data

Now, as it publishes what it calls a “further update”, it is confirmed that the report and the extremely expensive PR operation around it is nothing more than a cheap marketing stunt.

The report claimed to have tested 30 major UK CBD products that can be purchased from the UK high street or bought online. It presented alarming results showing that many of the products contained far less CBD than claimed and almost half contained illegal levels of THC and/or CBN. It refused to release information about which products were concerned with evasive answers and excuses that there were ‘legal implications’. Now, in its further update, surprise, surprise, it says that all its members’ products were within 10% of the CBD content indicated on the label.

As CLEAR reported at the time, the report is nothing but a market manipulation exercise. We didn’t expect their preference for their own products to come so quickly and so brazenly, which is why we now christen the whole exercise a cheap stunt. Certainly, there are some rogue businesses and fake products but the impression given by this report is false, misleading and wildly inaccurate. Consumers can be confident if they buy from members of the two trade associations Cannabis Professionals (CannaPro) or Cannabis Trades Association (CTA) they will be getting a quality product which is lab tested and contains exactly what is claimed.

CMC now defines itself as a trade body, although it only has two or three members in the CBD business in the UK, which were formerly members of the long-established trade associations. It should be noted that the so-called ‘independent’ laboratory it used for testing CBD products is itself a member of CMC.

Written by Peter Reynolds

July 18, 2019 at 1:09 pm

Mischievous ‘Centre for Medicinal Cannabis’ Report Smears UK CBD Industry With Misleading Data

leave a comment »

A new report from the Centre for Medicinal Cannabis (CMC) paints an appalling picture of the CBD market in the UK and has led to headlines and alarm everywhere that consumers are being ripped off and the whole industry is not to be trusted.

Cannabis has great medical potential. But don’t fall for the CBD scam – The Guardian

Calling on the UK CBD sector to have better regulation and reform – Health Europa

Centre for Medicinal Cannabis survey finds six million adults used CBD in UK – NHS Executive

CBD oil brands contain little to no CBD, test by Sativa’s UK lab reveals – Proactive Investors

It is true that there are some rogue businesses and fake products but the impression given by this report is false, misleading and wildly inaccurate.  For nearly three years the leading CBD businesses in the UK have been engaged in serious, responsible self-regulation and consumers can be confident if they buy from members of the two trade associations Cannabis Professionals (CannaPro) or Cannabis Trades Association (CTA) they will be getting a quality product which is lab tested and contains exactly what is claimed.

The report is nothing but a market manipulation exercise by the authors. To understand why, it’s necessary to understand who is behind the ‘Centre for Medicinal Cannabis’ and examine their record.

The CMC is the latest front for Paul Birch, a multimillionaire, who since 2015 has been funding a series of ventures in the cannabis campaign. Mr Birch has brought one extremely valuable commodity to the campaign which it had been sorely lacking – money.  He has hired a lot of people with the right connections, impressive letters after their name and has thrown a great deal of his cash into expensive PR which, to be fair, has proved very effective. In fact, as with this CBD report, it is characterised by just how much media coverage it has obtained.  This, of course, has earned Birch’s cannabis ventures a reputation as leaders in their field. In fact, they are very much followers.  The content of their work is either directly copied from others’ work or is just a repeat of what has been done before.

The most high profile success achieved with Birch’s money and PR was the campaign around Billy Caldwell and Alfie Dingley, two children with severe epilepsy, whose stories touched the heart of the nation and under enormous moral pressure forced the UK government into long-overdue reform of its blanket ban on cannabis as medicine.  Birch’s money certainly made all the difference. Exactly the same stories and messages had been delivered to the media many times before but it is a fact of life that you only get on to the breakfast and daytime TV shows and in all the tabloids with a very expensive PR operation.

So Birch is at it again with the CMC. It describes itself as the UK’s first and only industry membership body for businesses and investors operating in cannabis based medicinal products (CBMPs) and cannabidiol (CBD) wellness markets.“, which is as wholly false a claim as has ever been published about anything, anywhere.

The existing trade associations, CannaPro and the CTA, were formed years before the CMC and between them represent nearly 1,000 businesses operating in the legal cannabis sector.  Neither of them were consulted before or since the CMC’s report and the fact of their existence and the work they do in regulating the industry has been excluded from the report.

Of course, the CMC won’t name the products which its report showed to be so deficient because this would show that they are not from members of CannaPro or CTA and are therefore not at all representative of what consumers are actually buying. The irony is that PhytoVista, the lab used by the CMC, is itself a member of the CTA and provides testing services to many CannaPro and CTA members.

So take the results of the CMC CBD report with a very large pinch of salt, or perhaps with a tablespoon of hempseed oil containing only a trace of CBD.  It doesn’t tell the truth. It paints a false picture of an industry that is actually a model of self-regulation.

Written by Peter Reynolds

July 9, 2019 at 3:38 pm